IO Biotech, Inc. Insider Trading
IOBTQ
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in May 2025.
Get an email when IOBTQ's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | Heidi Hunter Director | Bought | 15,000 | $1.39 | 21K | New | Form 4 |
| Dec 23, 2024 | Qasim Iftikhar Ahmad Chief Medical Officer | Bought | 31,350 | $0.85 | 27K | New | Form 4 |
| Dec 23, 2024 | Mai-Britt Zocca Chief Executive Officer | Bought | 12,500 | $0.81 | 10K | 20% | Form 4 |
| Dec 23, 2024 | Amy Sullivan Chief Financial Officer | Bought | 10,250 | $0.83 | 9K | 14% | Form 4 |
| Dec 23, 2024 | Devin Whittemore Smith General Counsel | Bought | 12,000 | $0.81 | 10K | 243% | Form 4 |
- May 30, 2025Heidi HunterDirector · bought 15,000 at $1.3921KNew position
- Dec 23, 2024Qasim Iftikhar AhmadChief Medical Officer · bought 31,350 at $0.8527KNew position
- Dec 23, 2024Mai-Britt ZoccaChief Executive Officer · bought 12,500 at $0.8110K20% of stake
- Dec 23, 2024Amy SullivanChief Financial Officer · bought 10,250 at $0.839K14% of stake
- Dec 23, 2024Devin Whittemore SmithGeneral Counsel · bought 12,000 at $0.8110K243% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with IOBTQ
Spot a number that looks wrong? Check it in IOBTQ's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing IOBTQ
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.